Rinvoq ER 30 MG tablet UU 30S
Ended Awarded Last action
- Contract number
- SPE2DR26FVYN1
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $15,267
Award facts
- Contract value 100% obligated
- $15,266.77 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on January 26, 2026, for the supply of RINVOQ ER 30 MG tablets (30-count units) with a ceiling value of $15,266.77. This firm fixed-price delivery order, with an ultimate completion date of January 27, 2026, represents a non-set-aside competitive award and is executed under AmerisourceBergen's parent company Cencora, Inc.'s broader Indefinite Delivery Contract with DLA Troop Support Medical. That prime IDC, valued at $999,999,999.00 and extending through December 2031, serves as the comprehensive vehicle enabling AmerisourceBergen to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs globally, including specialty medications, brand-name and generic drugs, and critical medical commodities across multiple therapeutic domains.
AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania—the location of performance for this delivery order—is a major pharmaceutical distributor serving federal medical procurement needs. The company's extensive federal contract portfolio with the Defense Logistics Agency and its Medical Supply Chain demonstrates its capability to meet competitive procurement requirements for pharmaceutical and medical supply delivery to military treatment facilities, veterans' healthcare programs, and other federal medical institutions.
Quick answers
Who was awarded contract SPE2DR26FVYN1?
SPE2DR26FVYN1 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 26, 2026.
How much is contract SPE2DR26FVYN1 worth?
The government has obligated $15,267 on SPE2DR26FVYN1.
Is contract SPE2DR26FVYN1 an order under another contract?
Yes. SPE2DR26FVYN1 is a delivery order under SPE2DR25D3002, an indefinite delivery contract.
Was contract SPE2DR26FVYN1 competed?
The extent of competition for SPE2DR26FVYN1 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award